PET imaging with radioligands for amyloid-β or tau protein, such as 11C-PiB and 18F-MK-6240, respectively, is already being used to diagnose Alzheimer’s disease in living patients [164,165,166], replacing pathological diagnosis. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.